216 related articles for article (PubMed ID: 29915248)
1. Effect of tyrosine kinase inhibitors on renal handling of creatinine by MATE1.
Omote S; Matsuoka N; Arakawa H; Nakanishi T; Tamai I
Sci Rep; 2018 Jun; 8(1):9237. PubMed ID: 29915248
[TBL] [Abstract][Full Text] [Related]
2. Tucatinib Inhibits Renal Transporters OCT2 and MATE Without Impacting Renal Function in Healthy Subjects.
Topletz-Erickson AR; Lee AJ; Mayor JG; Rustia EL; Abdulrasool LI; Wise AL; Dailey B; DeChenne S; Walker LN; Alley SC; Endres CJ
J Clin Pharmacol; 2021 Apr; 61(4):461-471. PubMed ID: 32989831
[TBL] [Abstract][Full Text] [Related]
3. Role of organic cation transporter OCT2 and multidrug and toxin extrusion proteins MATE1 and MATE2-K for transport and drug interactions of the antiviral lamivudine.
Müller F; König J; Hoier E; Mandery K; Fromm MF
Biochem Pharmacol; 2013 Sep; 86(6):808-15. PubMed ID: 23876341
[TBL] [Abstract][Full Text] [Related]
4. Interactions of tyrosine kinase inhibitors with organic cation transporters and multidrug and toxic compound extrusion proteins.
Minematsu T; Giacomini KM
Mol Cancer Ther; 2011 Mar; 10(3):531-9. PubMed ID: 21252289
[TBL] [Abstract][Full Text] [Related]
5. Contribution of MATE1 to Renal Secretion of the NMDA Receptor Antagonist Memantine.
Müller F; Weitz D; Derdau V; Sandvoss M; Mertsch K; König J; Fromm MF
Mol Pharm; 2017 Sep; 14(9):2991-2998. PubMed ID: 28708400
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory Effect of Crizotinib on Creatinine Uptake by Renal Secretory Transporter OCT2.
Arakawa H; Omote S; Tamai I
J Pharm Sci; 2017 Sep; 106(9):2899-2903. PubMed ID: 28336299
[TBL] [Abstract][Full Text] [Related]
7. In Vitro Inhibition of Renal OCT2 and MATE1 Secretion by Antiemetic Drugs.
George B; Wen X; Jaimes EA; Joy MS; Aleksunes LM
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208557
[TBL] [Abstract][Full Text] [Related]
8. Changes of drug pharmacokinetics mediated by downregulation of kidney organic cation transporters Mate1 and Oct2 in a rat model of hyperuricemia.
Nishizawa K; Yoda N; Morokado F; Komori H; Nakanishi T; Tamai I
PLoS One; 2019; 14(4):e0214862. PubMed ID: 30951542
[TBL] [Abstract][Full Text] [Related]
9. Renal tubular secretion of pramipexole.
Knop J; Hoier E; Ebner T; Fromm MF; Müller F
Eur J Pharm Sci; 2015 Nov; 79():73-8. PubMed ID: 26360835
[TBL] [Abstract][Full Text] [Related]
10. Renal vectorial transport of berberine mediated by organic cation transporter 2 (OCT2) and multidrug and toxin extrusion proteins 1 (MATE1) in rats.
Shi R; Yang Y; Xu Z; Dai Y; Zheng M; Wang T; Li Y; Ma Y
Biopharm Drug Dispos; 2018 Jan; 39(1):47-58. PubMed ID: 29065218
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of concomitant administration of imatinib on cisplatin-induced nephrotoxicity focusing on renal organic cation transporter OCT2.
Tanihara Y; Masuda S; Katsura T; Inui K
Biochem Pharmacol; 2009 Nov; 78(9):1263-71. PubMed ID: 19540211
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of OCT2, MATE1 and MATE2-K as a possible mechanism of drug interaction between pazopanib and cisplatin.
Sauzay C; White-Koning M; Hennebelle I; Deluche T; Delmas C; Imbs DC; Chatelut E; Thomas F
Pharmacol Res; 2016 Aug; 110():89-95. PubMed ID: 27178732
[TBL] [Abstract][Full Text] [Related]
13. No Inhibition of MATE1/2K-Mediated Renal Creatinine Secretion Predicted With Ritonavir or Cobicistat.
Kikuchi R; Chiou WJ; Kasai MA; de Morais SM; Bow DAJ
J Pharm Sci; 2019 Sep; 108(9):3118-3123. PubMed ID: 31034908
[TBL] [Abstract][Full Text] [Related]
14. Quantitative Consideration of Clinical Increases in Serum Creatinine Caused by Renal Transporter Inhibition.
Nakada T; Kudo T; Ito K
Drug Metab Dispos; 2023 Sep; 51(9):1114-1126. PubMed ID: 36859345
[TBL] [Abstract][Full Text] [Related]
15. Importance of OCT2 and MATE1 for the Cimetidine-Metformin Interaction: Insights from Investigations of Polarized Transport in Single- And Double-Transfected MDCK Cells with a Focus on Perpetrator Disposition.
Müller F; Weitz D; Mertsch K; König J; Fromm MF
Mol Pharm; 2018 Aug; 15(8):3425-3433. PubMed ID: 29975542
[TBL] [Abstract][Full Text] [Related]
16. Impact on creatinine renal clearance by the interplay of multiple renal transporters: a case study with INCB039110.
Zhang Y; Warren MS; Zhang X; Diamond S; Williams B; Punwani N; Huang J; Huang Y; Yeleswaram S
Drug Metab Dispos; 2015 Apr; 43(4):485-9. PubMed ID: 25605813
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine kinase inhibitors noncompetitively inhibit MCT8-mediated iodothyronine transport.
Braun D; Kim TD; le Coutre P; Köhrle J; Hershman JM; Schweizer U
J Clin Endocrinol Metab; 2012 Jan; 97(1):E100-5. PubMed ID: 22031512
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanism of renal tubular secretion of the antimalarial drug chloroquine.
Müller F; König J; Glaeser H; Schmidt I; Zolk O; Fromm MF; Maas R
Antimicrob Agents Chemother; 2011 Jul; 55(7):3091-8. PubMed ID: 21518836
[TBL] [Abstract][Full Text] [Related]
19. Contribution of multidrug and toxin extrusion protein 1 (MATE1) to renal secretion of trimethylamine-N-oxide (TMAO).
Gessner A; König J; Fromm MF
Sci Rep; 2018 Apr; 8(1):6659. PubMed ID: 29704007
[TBL] [Abstract][Full Text] [Related]
20. Role of OCT2 and MATE1 in renal disposition and toxicity of nitidine chloride.
Li LP; Song FF; Weng YY; Yang X; Wang K; Lei HM; Ma J; Zhou H; Jiang HD
Br J Pharmacol; 2016 Aug; 173(16):2543-54. PubMed ID: 27324234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
